• Written by: (Investorideas.com newswire, breaking stock market
  • Fri, 16 Aug 2024
  •   United States

August 16, 2024 (Investorideas.com Newswire) The biopharmaceutical industry remained resilient in the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve.

Top 20 global biopharmaceutical companies report 4.3% growth in market capitalization in Q2 2024